Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie最新文献

{"title":"In Response to \"Clinical Characteristics Associated With Early Phase Psychosis and Comorbid Substance Use\": Methodological Concerns-Authors' Reply.","authors":"Jacob Cookey, Jacob McGavin, Candice E Crocker, Sherry H Stewart, Philip G Tibbo","doi":"10.1177/07067437231173211","DOIUrl":"10.1177/07067437231173211","url":null,"abstract":"","PeriodicalId":55283,"journal":{"name":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9456750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring Mediators of Mental Health Service Use Among Transgender Individuals in Ontario, Canada.","authors":"Alex Abramovich, W Ariel Gould, Nelson Pang, Claire de Oliveira, Tomisin Iwajomo, Myriam Vigny-Pau, Kinnon MacKinnon, June Sing Hong Lam, Paul Kurdyak","doi":"10.1177/07067437231171541","DOIUrl":"10.1177/07067437231171541","url":null,"abstract":"<p><strong>Objectives: </strong>To determine if and to what degree neighbourhood-level marginalization mediates mental health service use among transgender individuals.</p><p><strong>Methods: </strong>This retrospective cohort study identified 2,085 transgender individuals through data obtained from 4 outpatient community and hospital clinics in 3 large cities in Ontario, which were linked with administrative health data between January 2015 and December 2019. An age-matched 1:5 comparison cohort was created from the general population of Ontario. Outcome measures were analysed from March 2020 to May 2022. The primary outcome was mental health service utilization, which included mental health-related visits to primary care providers, psychiatrists, mental health- and self-harm-related emergency department visits, and mental health hospitalizations. Mediation variables included ethnic concentration, residential instability, dependency, and material deprivation at the neighbourhood level and were derived from the Ontario Marginalization Index.</p><p><strong>Results: </strong>This study identified 2,085 transgender individuals from participating outpatient community and hospital clinics, who were matched to the general population (<i>n</i> = 10,425). Overall, neighbourhood-level marginalization did not clinically mediate mental health service use. However, transgender individuals were more likely to be exposed to all forms of neighbourhood-level marginalization, as well as having higher rates of health service use across all outcome measures.</p><p><strong>Conclusions: </strong>In this study, mental health service use among transgender individuals was not clinically mediated by marginalization at the neighbourhood level. This study highlights the need to explore marginalization and mental health service use at the individual level to better understand the mental health disparities experienced by transgender individuals and to ensure that health-care services are inclusive and affirming.</p>","PeriodicalId":55283,"journal":{"name":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657585/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9498297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of Anticholinergic Burden on Verbal Memory Performance in First-Episode Psychosis.","authors":"Agnès Belkacem, Katie M Lavigne, Carolina Makowski, Mallar Chakravarty, Ridha Joober, Ashok Malla, Jai Shah, Martin Lepage","doi":"10.1177/07067437231179161","DOIUrl":"10.1177/07067437231179161","url":null,"abstract":"<p><strong>Objectives: </strong>Antipsychotics are widely used to treat first-episode psychosis but may have an anticholinergic burden, that is, a cumulative effect of medications that block the cholinergic system. Studies suggest that a high anticholinergic burden negatively affects memory in psychosis, where cognitive deficits, particularly those in verbal memory, are a core feature of the disease. The present study sought to replicate this in a large cohort of well-characterized first-episode psychosis patients. We expected that patients in the highest anticholinergic burden group would exhibit the poorest verbal memory compared to those with low anticholinergic burden and healthy controls at baseline (3 months following admission). We further hypothesized that over time, at month 12, patients' verbal memory performance would improve but would remain inferior to controls.</p><p><strong>Methods: </strong>Patients (<i>n</i>  =  311; low anticholinergic burden [<i>n</i>  =  241] and high anticholinergic burden [<i>n</i>  =  70], defined by a Drug Burden Index cut-off of 1) and healthy controls (<i>n</i>  =  128) completed a clinical and neurocognitive battery including parts of the Wechsler Memory Scale at months 3 and 12.</p><p><strong>Results: </strong>Cross-sectionally, using an analysis of variance, patients in the highest anticholinergic burden group had the poorest performance in verbal memory when compared to the other groups at month 3, <i>F</i>(2,430)  =  52.33, <i>P</i> < 0.001. Longitudinally, using a Generalized Estimating Equation model, the verbal memory performance of all groups improved over time. However, patients' performance overall remained poorer than the controls.</p><p><strong>Conclusion: </strong>These findings highlight the importance of considering the anticholinergic burden when prescribing medications in the early stages of the disease.</p>","PeriodicalId":55283,"journal":{"name":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657580/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9918603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Surveillance of Child and Youth Mental Disorders and Associated Service Use in Canada.","authors":"Jordan Edwards,&nbsp;Paul Kurdyak,&nbsp;Charlotte Waddell,&nbsp;Scott B Patten,&nbsp;Graham J Reid,&nbsp;Leslie Anne Campbell,&nbsp;Katholiki Georgiade","doi":"10.1177/07067437231182059","DOIUrl":"10.1177/07067437231182059","url":null,"abstract":"","PeriodicalId":55283,"journal":{"name":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10091472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Heterogeneity in the Course of Suicidal Ideation and its Relation to Suicide Attempts in First-Episode Psychosis: A 5-Year Prospective Study.","authors":"Roxanne Sicotte,&nbsp;Srividya N Iyer,&nbsp;Éric Lacourse,&nbsp;Jean R Séguin,&nbsp;Amal Abdel-Baki","doi":"10.1177/07067437231167387","DOIUrl":"10.1177/07067437231167387","url":null,"abstract":"<p><strong>Objectives: </strong>Although the risk of suicide is high in first-episode psychosis (FEP), little is known about the course of suicidal ideation and its relation to suicide attempts. Therefore, we aimed to identify 5-year trajectories of suicidal ideation and associated factors in FEP and compare how suicide attempts were distributed across these identified trajectories.</p><p><strong>Method: </strong>This 5-year prospective study assessed suicidal ideation, suicide attempts and potentially associated factors through research interviews, chart review and coroners' reports in 382 FEP patients [mean age = 23.53 (<i>SD</i> = 3.61)] admitted to 2 5-year early psychosis services in Montreal, Canada. Trajectories were identified using a semiparametric mixture model, and associated factors with multinomial logistic regression.</p><p><strong>Results: </strong>Three suicidal ideation trajectories were identified: <i>low and decreasing</i> (<i>n</i> = 325, 85.08%); <i>early decline, then increasing</i> (<i>n</i> = 30, 7.85%), and <i>persistent suicidal ideation</i> (<i>n</i> = 27, 7.07%). Suicidal ideation prior to admission (OR = 2.85, 95% CI, 1.23 to 6.63, <i>P </i>< 0.05) and cocaine use disorder (OR = 6.78, 95% CI, 1.08 to 42.75, <i>P </i>< 0.05) were associated with the <i>early decline, then increasing suicidal ideation</i> trajectory. Persons with prior suicide ideation (OR = 4.33, 95% CI, 1.66 to 11.29, <i>P </i>< 0.05) and attempts (OR = 8.18, 95% CI, 2.39 to 27.97, <i>P </i>< 0.001) and alcohol use disorder (OR = 3.63, 95% CI, 1.4 to 9.42, <i>P </i>< 0.05) were more likely to belong to the <i>persistent suicidal ideation</i> trajectory, and to attempt suicide during follow-up.</p><p><strong>Conclusions: </strong>Our study highlights heterogeneity in the course of suicidal ideation over 5 years and the importance of ongoing assessment of suicidal risk in FEP patients, particularly for patients who persistently report suicidal ideation, as they are likelier to engage in suicide attempts. Patients with factors associated with increasing or persistent suicidal ideation trajectories should be targeted for suicide prevention interventions from the early phase of follow-up. Given the small number of persons in these trajectories and the wide CIs for some factors, larger studies are however needed to further characterize who belongs in each group.</p>","PeriodicalId":55283,"journal":{"name":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590090/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9323420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Changes in mortality for the general population and individuals with pre-pandemic acute care for alcohol or opioids during the COVID-19 pandemic in Ontario, Canada.","authors":"Daniel Thomas Myran,&nbsp;Erik Loewen Friesen,&nbsp;Michael Pugliese,&nbsp;Christina Milani,&nbsp;Peter Tanuseputro","doi":"10.1177/07067437231156000","DOIUrl":"10.1177/07067437231156000","url":null,"abstract":"","PeriodicalId":55283,"journal":{"name":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931873/pdf/10.1177_07067437231156000.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10726030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mental Health and the Climate Crisis: A Call to Action for Canadian Psychiatrists.","authors":"Daniel Rosenbaum, Sarah Levitt","doi":"10.1177/07067437231175532","DOIUrl":"10.1177/07067437231175532","url":null,"abstract":"","PeriodicalId":55283,"journal":{"name":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590088/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9929542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of a Publicly-Funded Pharmacare Program on Prescription Stimulant use Among Children and Youth: A Population-Based Observational Natural Experiment.","authors":"Tony Antoniou,&nbsp;Daniel McCormack,&nbsp;Sophie Kitchen,&nbsp;Kathleen Pajer,&nbsp;William Gardner,&nbsp;Yona Lunsky,&nbsp;Melanie Penner,&nbsp;Mina Tadrous,&nbsp;Muhammad Mamdani,&nbsp;David N Juurlink,&nbsp;Tara Gomes","doi":"10.1177/07067437231166836","DOIUrl":"10.1177/07067437231166836","url":null,"abstract":"<p><strong>Objective: </strong>Stimulants are first-line pharmacotherapy for individuals with attention-deficit hyperactivity disorder. However, disparities in drug coverage may contribute to inequitable treatment access. In January 2018, the government of Ontario, Canada, implemented a publicly-funded program (OHIP+) providing universal access to medications at no cost to children and youth between the ages of 0 and 24. In April 2019, the program was amended to cover only children and youth without private insurance. We studied whether these policy changes were associated with changes in prescription stimulant dispensing to Ontario children and youth.</p><p><strong>Methods: </strong>We conducted a population-based observational natural experiment study of stimulant dispensing to children and youth in Ontario between January 2013 and March 2020. We used interventional autoregressive integrated moving average models to estimate the association between OHIP+ and its subsequent modification with stimulant dispensing trends.</p><p><strong>Results: </strong>The implementation of OHIP+ was associated with a significant immediate increase in the monthly rate of stimulant dispensing of 53.6 individuals per 100,000 population (95% confidence interval [CI], 36.8 to 70.5 per 100,000) and a 14.2% (95% CI, 12.8% to 15.6%) relative percent increase in stimulant dispensing rates between December 2017 and March 2019 (1198.6 vs. 1368.7 per 100,000 population). The April 2019 OHIP+ program amendment was associated with an increase in monthly stimulant dispensing trends of 10.2 individuals per 100,000 population (95% CI, 5.0 to 15.5), with rates increasing 7.5% (95% CI, 6.2% to 8.7%) between March 2019 and March 2020 (1368.7 vs. 1470.8 per 100,000 population). These associations were most pronounced among males, children and youth living in the highest income neighbourhoods and individuals aged 20 to 24.</p><p><strong>Conclusion: </strong>A publicly-funded pharmacare program was associated with more children and youth being dispensed stimulants.</p>","PeriodicalId":55283,"journal":{"name":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/19/a4/10.1177_07067437231166836.PMC10590092.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9456498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Do Anxiety Symptoms Mediate the Association Between Cannabis Use Frequency and Psychotic-Like Experiences in Emerging Adult Undergraduates?","authors":"Haley C R Bernusky,&nbsp;Philip G Tibbo,&nbsp;Patricia J Conrod,&nbsp;Fakir Md Yunus,&nbsp;Matthew T Keough,&nbsp;Kara D Thompson,&nbsp;Marvin D Krank,&nbsp;Allyson F Hadwin,&nbsp;Sherry H Stewart","doi":"10.1177/07067437231176900","DOIUrl":"10.1177/07067437231176900","url":null,"abstract":"<p><strong>Objective: </strong>Cannabis is commonly used by Canadian emerging adults (ages 18-25 years), many of whom attend post-secondary institutions. Frequent cannabis use is linked with psychotic-like experiences (PLEs); however, the exact nature of this association remains unclear. Anxiety symptoms may mediate this association, as they are prevalent in emerging adults and have been independently linked with both cannabis use and PLEs. Past work found that anxiety mediated the association between cannabis use frequency and attenuated positive psychotic symptoms (further along the psychosis continuum than PLEs), however this research had yet to be validated in the Canadian population, and trait rather than state anxiety (frequency of anxiety symptoms) was studied. Thus, our primary objective was to examine if anxiety symptoms mediated the association between cannabis use frequency and PLEs in Canadian emerging adult undergraduates. Despite known sex differences in cannabis use, expression of anxiety, and PLEs, past work did not evaluate the potential impact of biological sex on the anxiety-mediated model, and thus is the secondary objective of the present study.</p><p><strong>Methods: </strong>1,266 first-/second-year emerging adult undergraduates from five Canadian universities provided cross-sectional, self-report survey data in fall 2021 semester. Validated measures of cannabis use frequency, anxiety, and PLEs were administered.</p><p><strong>Results: </strong>Path analyses supported mediation from cannabis use to PLEs through anxiety (<i>b</i>  =  0.07, <i>P</i> < 0.001, 95% bootstrap CI [0.03, 0.10]). No direct effect was found (<i>P</i>  =  0.457), suggesting that the cannabis-to-PLEs association was mediated by anxiety. Mediation did not depend on biological sex (i.e., bootstrapped 95% CIs crossed zero).</p><p><strong>Conclusions: </strong>Anxiety symptoms mediated the association between cannabis use and PLEs in emerging adults regardless of their biological sex. Assuming replication in prospective research, results highlight anxiety as an important intervention target in frequent cannabis-using emerging adults, to potentially prevent development/worsening of PLEs, and in turn psychotic illness.</p>","PeriodicalId":55283,"journal":{"name":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590089/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9476964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Amphetamine-Related Emergency Department Visits in Ontario, Canada, 2003-2020.","authors":"James A G Crispo,&nbsp;Lisa Liu,&nbsp;Paxton Bach,&nbsp;Dominique R Ansell,&nbsp;Branavan Sivapathasundaram,&nbsp;Francis Nguyen,&nbsp;Paul Kurdyak,&nbsp;Dallas P Seitz,&nbsp;Michael Conlon,&nbsp;Jacquelyn J Cragg","doi":"10.1177/07067437231158933","DOIUrl":"10.1177/07067437231158933","url":null,"abstract":"<p><strong>Objectives: </strong>Despite unregulated amphetamine use increasing, there are limited data on related emergency department (ED) visits in Canada. Our primary objective was to examine trends in amphetamine-related ED visits over time in Ontario, including by age and sex. Secondary objectives were to examine whether patient characteristics were associated with ED revisit within 6 months.</p><p><strong>Methods: </strong>Using administrative claims and census data, we calculated annual patient- and encounter-based rates of amphetamine-related ED visits from 2003 to 2020 among individuals 18+ years of age. We also performed a retrospective cohort study of individuals with amphetamine-related ED visits between 2019 and 2020 to determine whether select factors were associated with ED revisit within 6 months. Multivariable logistic regression modelling was used to measure associations.</p><p><strong>Results: </strong>The population-based rate of amphetamine-related ED visits increased nearly 15-fold between 2003 (1.9/100,000 Ontarians) and 2020 (27.9/100,000 Ontarians). Seventy-five percent of individuals returned to the ED for any reason within 6 months. Psychosis and use of other substances were both independently associated with ED revisit for any reason within 6 months (psychosis: AOR = 1.54, 95% CI = 1.30-1.83; other substances: AOR = 1.84, 95% CI = 1.57-2.15), whereas having a primary care physician was negatively associated with ED revisit (AOR = 0.77, 95% CI = 0.60-0.98).</p><p><strong>Conclusions: </strong>Increasing rates of amphetamine-related ED visits in Ontario are cause for concern. Diagnoses of psychosis and the use of other substances may serve to identify individuals who are most likely to benefit from both primary and substance-specific care.</p>","PeriodicalId":55283,"journal":{"name":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/33/10.1177_07067437231158933.PMC10590093.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9430022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}